Aims and Scope

OncoDaily Medical Journal, the official journal of the Immune Oncology Research Institute, is dedicated to advancing the field of oncology by comprehensively covering all facets of cancer research and treatment. As a peer-reviewed, open-access journal, we provide a platform for the international oncology community to disseminate significant advancements and clinical developments that aid in treating various cancer types. Emphasizing a multidisciplinary approach, OncoDaily Medical Journal encourages submissions across a broad spectrum of oncological research. We are committed to facilitating the exchange of innovative ideas and findings among researchers, clinicians, and healthcare professionals worldwide, thereby contributing to the enhanced management and care of patients with cancer. This journal embraces a wide range of study types in oncology, promoting research that spans from molecular science to clinical trials and patient care strategies.

Editorial Leadership

The journal is under the editorial guidance of Editor-in-Chief Dr. Shushan Hovsepyan and Chair of the Editorial Board Dr. Matti Aapro. OncoDaily Medical Journal is dedicated to delivering high-quality communications within the rapidly evolving oncology field, supported by a broad international editorial board of renowned experts.

Open Access Policy

OncoDaily Medical Journal is dedicated to disseminating medical knowledge freely and universally through our open access policy. This approach ensures that researchers worldwide can access, use, and build upon the work published in our journal.

Journal Sections

Our journal is structured into specialized sections, each led by expert editors who ensure that the content meets the highest standards of rigor and relevance. When submitting, authors are encouraged to choose the section that best aligns with their research to facilitate a fair and expert review process.